Skip to main content
. 2020 Sep 28;23(1):75–85. doi: 10.1111/dom.14189

FIGURE 4.

FIGURE 4

Subgroup analyses of cardiorenal disease in patients with type 2 diabetes free from cardiovascular and renal disease. ER, event rates; PY, patient‐years; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blockers; DPP4i, dipeptidyl peptidase‐4 inhibitor; loop diuretics, high ceiling diuretics; RAASi, renin angiotensin aldosterone system inhibitor; SGLT2i, sodium‐glucose cotransporter‐2 inhibitor